HIGHLIGHTS   |  November 14, 2019   FDA Approves Luspatercept to Treat Beta Thalassemia–Associated Anemia The agency approved the first and only FDA-approved erythroid maturation agent to treat anemia in adult patients with beta thalassemia who require regular red blood cell transfusions. Read more     FDA Grants Priority Review to Opdivo-Yervoy Combo in Advanced HCC The FDA has accepted the supplemental biologics license application and granted breakthrough therapy designation to nivolumab plus ipilimumab for the treatment of patients with advanced hepatocellular carcinoma previously treated with sorafenib. Read more IN CASE YOU MISSED IT   Role of COX7RP in Endometrial, Breast Cancer Growth Researchers in Japan recently investigated the contributions of mitochondrial respiration in tumorigenesis, as these respirations produce ATP and cancerous metabolites that give cancer cells a boost. Read more